LEO Pharma AS:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:LEO Pharma AS - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7174
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:29
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
LEO Pharma A/S (LEO Pharma), a subsidiary of LEO Foundation is a research-based pharmaceutical company. It discovers, develops, manufactures and commercializes pharmaceuticals in therapeutic areas dermatology and thrombosis. The company focuses on the treatment of diseases such as psoriasis, eczema, skin infections, actinic keratosis and non-melanoma skin cancer, besides thrombosis. It also manufactures and markets products for the treatment of diseases in the areas of cardiovascular, bacterial infections, coagulation, osteoporosis and renal care. LEO Pharma markets its products worldwide and has presence in countries across Europe, the Middle East, Africa, Asia, North America, Central America, South America and Oceania. LEO Pharma is headquartered in Ballerup, Denmark.

LEO Pharma AS – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LEO Pharma A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LEO Pharma A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
LEO Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
LEO Pharma A/S, Medical Equipment, Deal Details 10
Partnerships 10
Leo Pharma Enters into Licensing Agreement with Klox Technologies 10
LEO Pharma and FibroTx Enter into Partnership 11
Almirall and Leo Pharma Enter into Agreement 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
LEO Pharma A/S – Key Competitors 14
LEO Pharma A/S – Key Employees 15
LEO Pharma A/S – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 19
Financial Announcements 19
Mar 02, 2018: A record year for LEO Pharma 19
Apr 03, 2017: LEO Pharma 2016 result surpassed expectations 21
Corporate Communications 23
Aug 28, 2018: LEO Pharma appointed Olivier Bohuon as Board Director 23
May 28, 2018: LEO Pharma Names Christian Antoni as Senior Vice President for Global Development, R&D 24
Mar 20, 2018: LEO Pharma Appoints Rhonda Duffy To Lead Global Product Supply 25
Jun 23, 2017: LEO Pharma Appoints Chris Posner to Lead US Business 26
Other Significant Developments 27
Apr 12, 2018: LEO Pharma makes its first investment in microbiome technology – enters partnership with microbiome-therapeutics company Naked Biome 27
Mar 05, 2018: LEO Pharma and International Health Partners enter into partnership to help people in need 28
Appendix 29
Methodology 29
About GlobalData 29
Contact Us 29
Disclaimer 29

List of Tables
LEO Pharma A/S, Medical Equipment, Key Facts, 2017 2
LEO Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LEO Pharma A/S, Medical Equipment Deals By Type, 2012 to YTD 2018 6
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LEO Pharma A/S, Deals By Market, 2012 to YTD 2018 8
LEO Pharma A/S, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Leo Pharma Enters into Licensing Agreement with Klox Technologies 10
LEO Pharma and FibroTx Enter into Partnership 11
Almirall and Leo Pharma Enter into Agreement 12
Klox Technologies and LEO Pharma to Form Joint Venture 13
LEO Pharma A/S, Key Competitors 14
LEO Pharma A/S, Key Employees 15
LEO Pharma A/S, Subsidiaries 16

List of Figures
LEO Pharma A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
LEO Pharma A/S, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
LEO Pharma A/S, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
LEO Pharma A/S, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
LEO Pharma A/S, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[LEO Pharma AS:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Ship Finance International Ltd (SFL):石油・ガス:M&Aディール及び事業提携情報
    Summary Ship Finance International Ltd (Ship Finance International) is a provider of bulker, tanker, container, and offshore solutions. The company offers fleet of vessels such as crude oil tankers for ultra-deep water semi-submersible dry bulk carriers and drilling rigs, among others. It also opera …
  • Sun Pharmaceutical Industries Ltd (SUNPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary Sun Pharmaceutical Industries Ltd (Sun Pharma) is a specialty pharmaceutical company, which offers a wide range of pharmaceutical formulations such as branded generics and generic pharmaceuticals. The company’s products find application in the treatment of various conditions related to psych …
  • Sumitomo Corporation (8053)-エネルギー分野:企業M&A・提携分析
    Summary Sumitomo Corporation (Sumitomo) is a multifaceted business enterprise. It operates various businesses such as metal products, transportation, construction systems, infrastructure, media, network & lifestyle retail, general products, real estate, financial services, logistics, mineral resourc …
  • Oasis Petroleum Inc (OAS):企業の財務・戦略的SWOT分析
    Oasis Petroleum Inc (OAS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Gerdau S.A. (GGBR4):企業の財務・戦略的SWOT分析
    Gerdau S.A. (GGBR4) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Sectra AB (SECT B):医療機器:M&Aディール及び事業提携情報
    Summary Sectra AB (Sectra) develops and sells technologies for medical systems and secure communication systems. Its operations are concentrated on two major sectors: Image IT Solutions and Secure Communications. The company’s subsidiary, Sectra Imaging IT Solutions AB, offers medical information te …
  • POP Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary POP Biotechnologies Inc (POP Biotechnologies) is a biotechnology company that develops and harnesses nano-scale technologies. The company’s product portfolio comprises of NP-01, an encapsulated nanoparticle used to impart systemic drug release; and C36 product, a cobalt indulged nanoparticle …
  • Genentech, Inc.:企業の戦略・SWOT・財務情報
    Genentech, Inc. - Strategy, SWOT and Corporate Finance Report Summary Genentech, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Piraeus Bank SA:企業のM&A・事業提携・投資動向
    Piraeus Bank SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Piraeus Bank SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • 3-D Matrix Inc:企業の戦略的SWOT分析
    3-D Matrix Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Cinemark Holdings Inc (CNK):企業の財務・戦略的SWOT分析
    Cinemark Holdings Inc (CNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Histogenics Corp (HSGX):企業の財務・戦略的SWOT分析
    Summary Histogenics Corp (Histogenics) is a regenerative medicine company that develops, markets and commercializes products for musculoskeletal disorders. The company provides product such as neocart, a tissue implant produced using a patient’s own cartilage cells which are harvested from non-weigh …
  • Amec Foster Wheeler plc (formerly AMEC plc):戦略・SWOT・企業財務分析
    Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report Summary Amec Foster Wheeler plc (formerly AMEC plc) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation …
  • Airbnb Inc:企業の戦略・SWOT・財務情報
    Airbnb Inc - Strategy, SWOT and Corporate Finance Report Summary Airbnb Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Champions Oncology Inc (CSBR):製薬・医療:M&Aディール及び事業提携情報
    Summary Champions Oncology Inc (Champions), formerly Champions Biotechnology Inc, is a developer of advanced technology solutions and services to personalize the development and use of oncology drugs. The company’s technology platform is an approach based upon the implantation of primary human tumor …
  • Boule Diagnostics AB (BOUL):医療機器:M&Aディール及び事業提携情報
    Summary Boule Diagnostics AB (Boule) is a medical device company that offers hematology diagnostic solutions. The company provides systems and consumer products for complete blood counts to non-institutional healthcare. It offers products such as blood cell counter and instruments, reagents, calibra …
  • Tempo Beverages Ltd.:企業の戦略・SWOT・財務分析
    Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report Summary Tempo Beverages Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Air Canada:企業の戦略・SWOT・財務情報
    Air Canada - Strategy, SWOT and Corporate Finance Report Summary Air Canada - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Dialog Group Bhd (DIALOG):企業の財務・戦略的SWOT分析
    Dialog Group Bhd (DIALOG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Acuity Brands, Inc.:企業の戦略・SWOT・財務分析
    Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report Summary Acuity Brands, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆